Medtronic CE marks Reclaim DBS device for OCD - UPDATE
This article was originally published in Clinica
Executive Summary
Medtronic's Reclaim has become the first deep brain stimulation (DBS) device to be approved in Europe for a psychiatric illness, after the company CE marked it for obsessive compulsive disorder (OCD). Its intended use is in patients with chronic, severe, treatment-resistant disease – over 1,000 European patients per year could benefit, Medtronic estimates.